SCM
ORMP icon

Sage Capital Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Sage Capital Management’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$84K Hold
17,977
– – 0.03% 161
2026
Q2 		$86.5K Hold
17,977
– – 0.03% 162
2026
Q1 		$61.1K Buy
17,977
+1,227
+7% +$4.16K 0.03% 163
2025
Q4 		$47.7K Hold
16,750
– – 0.02% 161
2025
Q3 		$44.2K Hold
16,750
– – 0.02% 157
2025
Q2 		$37.7K Hold
16,750
– – 0.02% 157
2025
Q1 		$35.8K Hold
16,750
– – 0.02% 151
2024
Q4 		$40.5K Hold
16,750
– – 0.02% 154
2024
Q3 		$40.9K Hold
16,750
– – 0.02% 159
2024
Q2 		$43K Hold
16,750
– – 0.02% 152
2024
Q1 		$48.9K Buy
+16,750
New +$46.8K 0.03% 149

Other funds holding ORMP

Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Redwood Family Wealth
Redwood Family Wealth Addison, Texas $113M AUM 24.54% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Sage Capital Management's ORMP Position: Q3 2026 in Review

Sage Capital Management held its Oramed Pharmaceuticals (ORMP) position steady in Q3 2026 at 17,977 shares worth $84K. The position accounts for 0.03% of the portfolio, ranked #161.

Sage Capital Management first reported a position in ORMP in Q1 2024 and has held it in 11 quarters since. The position peaked at $86.5K in Q2 2026. 8 funds tracked by Wall St. Rank hold ORMP as of Q3 2026.

  • Sage Capital Management held 17,977 shares of Oramed Pharmaceuticals worth $84K as of Q3 2026.
  • Sage Capital Management left its Oramed Pharmaceuticals share count unchanged in Q3 2026.
  • Oramed Pharmaceuticals made up 0.03% of Sage Capital Management's portfolio in Q3 2026, its #161 holding.
  • Sage Capital Management first reported a position in Oramed Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
  • Sage Capital Management's Oramed Pharmaceuticals position peaked at $86.5K in Q2 2026.
  • 8 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2026.

Based on Sage Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.